Department of Neurology, Chi Mei Medical Center, Tainan, Taiwan.
Chia Nan University of Pharmacy & Science, Tainan, Taiwan.
Disabil Rehabil. 2022 May;44(10):2099-2103. doi: 10.1080/09638288.2020.1814429. Epub 2020 Sep 9.
To compare the test-retest reliability and random measurement errors of the Barthel Index (BI) and modified Barthel Index (MBI) in patients with chronic stroke.
The intraclass correlation coefficient (ICC) and the minimal detectable change (MDC) were applied respectively to examine the test-retest reliability (about 2 weeks apart) and the random measurement errors. The MDC% was used to adjust the cut-off score for determining whether a real change had been achieved, if heteroscedasticity existed.
A total of 60 patients participated. The BI and MBI both had high ICCs (0.94 and 0.94, respectively) with small MDCs (16.2 and 15.4, respectively) and MDC%s (21.2% and 19.0%, respectively), indicating that both measures have comparable reliability in repeated assessments. However, moderate associations ( = -0.47 for the BI and -0.59 for the MBI) were found between the means of tests and retests and the absolute values of change scores, indicating heteroscedasticity. These findings suggest that a fixed MDC value is not appropriate for determining the real change in both measures because the amount of random measurement error varies with the patients' ADL function.
The MBI, which showed excellent test-retest reliability and relatively lower random measurement error than the BI, appears to be a better ADL measure. The MDC% adjusted value is recommended to determine whether the change scores are beyond random measurement error.IMPLICATIONS FOR REHABILITATIONThe MBI is recommended for clinical and research applications because it has better test-retest reliability and relatively lower random measurement error than those of the original BI.The MDC% adjusted value is recommended to determine whether the change scores are beyond random measurement error when the MBI or the BI is used.
比较慢性脑卒中患者Barthel 指数(BI)和改良Barthel 指数(MBI)的重测信度和随机测量误差。
分别采用组内相关系数(ICC)和最小可检测变化量(MDC)来检测重测信度(相隔约 2 周)和随机测量误差。如果存在异方差性,则使用 MDC%来调整确定是否实现真实变化的截止分数。
共有 60 名患者参与。BI 和 MBI 的 ICC 均较高(分别为 0.94 和 0.94),MDC 较小(分别为 16.2 和 15.4),MDC%较低(分别为 21.2%和 19.0%),表明两种测量方法在重复评估中均具有较高的可靠性。然而,测试和重测的均值与变化得分的绝对值之间存在中度相关性(BI 为 -0.47,MBI 为 -0.59),表明存在异方差性。这些发现表明,对于两种测量方法,固定的 MDC 值并不适合确定真实变化,因为随机测量误差的量随患者的 ADL 功能而变化。
MBI 显示出优异的重测信度和相对较低的随机测量误差,优于 BI,似乎是一种更好的 ADL 测量方法。建议使用 MDC%调整值来确定变化得分是否超出随机测量误差。
MBI 因其具有比原始 BI 更好的重测信度和相对较低的随机测量误差,建议在临床和研究应用中使用。
当使用 MBI 或 BI 时,建议使用 MDC%调整值来确定变化得分是否超出随机测量误差。